Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 13, 2009

Sigma-Aldrich Takes Over Distributor in Chile

  • Sigma-Aldrich purchased Sigal, its primary distributor in Chile, and established Sigma-Aldrich Quimica. This will provide a foundation for future growth in the country.

    “Building on our strong customer base in Chile and throughout Latin America is a long-term strategy for Sigma-Aldrich,” explains Eric Green, vp of international sales and operations. "We experienced 20% sales growth in Latin America in 2008 alone."

    Sigma-Aldrich's strategic plan also includes accelerating growth in Canada and Asia Pacific. The firm’s  goal is that 25% of corporate sales by 2010 come from these regions along with Latin America. In October 2008 Sigma-Aldrich established a representative office in Vietnam to serve the country's research and manufacturing sectors.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »